{"id":31961,"date":"2023-10-20T14:26:28","date_gmt":"2023-10-20T14:26:28","guid":{"rendered":"http:\/\/startupsmart.test\/2023\/10\/20\/tech-insiders-want-journalists-to-give-founders-the-benefit-of-the-doubt-startupsmart\/"},"modified":"2023-10-20T14:26:28","modified_gmt":"2023-10-20T14:26:28","slug":"tech-insiders-want-journalists-to-give-founders-the-benefit-of-the-doubt-startupsmart","status":"publish","type":"post","link":"https:\/\/www.startupsmart.com.au\/uncategorized\/tech-insiders-want-journalists-to-give-founders-the-benefit-of-the-doubt-startupsmart\/","title":{"rendered":"Tech insiders want journalists to give founders the benefit of the doubt – StartupSmart"},"content":{"rendered":"
A number of prominent tech investors believe that when it comes to startup founders, the media should give them the benefit of the doubt.<\/p>\n
\u00a0<\/p>\n
Business Insider\u2019s <\/i>Matt Rosoff <\/a> explores this critique of tech journalism, made by a number of tech insiders in the wake of a Wall Street Journal<\/i> expose of a medical startup<\/a> Theranos and a confrontational interview with food startup Hampton Creek.<\/p>\n \u00a0<\/p>\n The WSJ <\/em>piece alleges that Theranos, a startup offering quicker and cheaper blood tests valued at $US9 billion, isn\u2019t actually using its proprietary technology in most cases, and is instead relying on the traditional methods.<\/p>\n \u00a0<\/p>\n Many prominent Silicon Valley figures rallied to the company\u2019s defence, arguing that the benefit of the doubt should be given to startup founders.<\/p>\n \u00a0<\/p>\n \u201cI would bet that the real Theranos story is a ton of people working really hard to change medical tests and are close to something amazing,\u201d venture capitalist Josh Elman tweeted<\/a>.<\/p>\n \u00a0<\/p>\n \u201cThe question is only whether they fully achieve that amazing potential and can deliver to the market or if they just remain close.\u201d<\/p>\n \u00a0<\/p>\n